India approves Russia's Sputnik V

India has approved the Russian Sputnik V coronavirus vaccine for emergency use, The Times of India newspaper wrote. 

India already uses the local Covaxin vaccine and the drug by Swedish-British company AstraZeneca, which is marketed there under the name Covishield.

Earlier, Russia's Sputnik V vaccine was approved in Panama. The Central American Republic has thus become the 59th country to register Sputnik V vaccine.

Sputnik V was developed by the Gamaleya Research Center. It became the world's first registered vaccine against COVID-19 based on the human adenovirus. Currently, the Russian vaccine is among ten best vaccine candidates on the list of the World Health Organization (WHO).

Subscribe to Pravda.Ru Telegram channel, Facebook, Twitter, YouTube, RSS!

Author`s name: Editorial Team